Published in Clin Infect Dis on July 01, 1992
Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrob Agents Chemother (1994) 3.02
Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae. Antimicrob Agents Chemother (2003) 1.62
Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (2000) 1.52
Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis (2005) 1.46
Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother (1999) 1.41
Comparison of phenotypic characteristics, DNA-DNA hybridization results, and results with a commercial rapid biochemical and enzymatic reaction system for identification of viridans group streptococci. J Clin Microbiol (1995) 1.37
In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood. Antimicrob Agents Chemother (1995) 1.35
Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis. Antimicrob Agents Chemother (1997) 1.27
Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol (1999) 1.24
In vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients. Antimicrob Agents Chemother (1996) 1.20
Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci. Antimicrob Agents Chemother (1999) 1.12
In vitro activities of the new ketolide HMR 3647 (telithromycin) in comparison with those of eight other antibiotics against viridans group Streptococci isolated from blood of neutropenic patients with cancer. Antimicrob Agents Chemother (2001) 0.95
A randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis. Antimicrob Agents Chemother (1994) 0.91
Development of a DNA probe for Streptococcus bovis by using a cloned amylase gene. J Clin Microbiol (1993) 0.88
Meningitis due to Streptococcus salivarius. J Clin Microbiol (2001) 0.87
Susceptibilities of oral and nasal isolates of Streptococcus mitis and Streptococcus oralis to macrolides and PCR detection of resistance genes. Antimicrob Agents Chemother (2000) 0.84
E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci. J Clin Microbiol (1999) 0.83
All detectable high-molecular-mass penicillin-binding proteins are modified in a high-level beta-lactam-resistant clinical isolate of Streptococcus mitis. Antimicrob Agents Chemother (2001) 0.81
A chimeolysin with extended-spectrum streptococcal host range found by an induced lysis-based rapid screening method. Sci Rep (2015) 0.79
Streptococcus mitis cell walls and lipopolysaccharide induce lethality in D-galactosamine-sensitized mice by a tumor necrosis factor-dependent pathway. Infect Immun (1996) 0.79
Use of the quinolones in the prophylaxis and treatment of granulocytopenic immunocompromised cancer patients. Drugs (1993) 0.78
Lack of ability of ciprofloxacin-rifampin prophylaxis to decrease infection-related morbidity in neutropenic patients given cytotoxic therapy and peripheral blood stem cell transplants. Antimicrob Agents Chemother (1997) 0.78
The involvement of CD14 in the activation of human monocytes by peptidoglycan monomers. Mediators Inflamm (2001) 0.78
Antibacterial activity in serum and urine as a therapeutic guide in bacterial infections. J Infect Dis (1974) 5.47
Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis (1999) 3.39
Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother (1972) 3.21
Fungal infections in cancer patients: an international autopsy survey. Eur J Clin Microbiol Infect Dis (1992) 3.16
Carbenicillin and hypokalemia. Ann Intern Med (1973) 2.83
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Significance of antimicrobial synergism for the outcome of gram negative sepsis. Am J Med Sci (1977) 2.28
Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopenia. Am J Med (1984) 2.17
Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria. Antimicrob Agents Chemother (1986) 2.12
Association between antifungal prophylaxis and rate of documented bacteremia in febrile neutropenic cancer patients. Clin Infect Dis (2001) 2.03
Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. J Infect Dis (1978) 1.89
Cephradine. Antibacterial activity and clinical effectiveness. Chemotherapy (1973) 1.88
Antistaphylococcal activity of rifampin with other antibiotics. J Infect Dis (1981) 1.78
Genome screen for asthma and related phenotypes in the French EGEA study. Am J Respir Crit Care Med (2000) 1.75
Comparison of amikacin and gentamicin. Clin Pharmacol Ther (1975) 1.73
Antipseudomonal drugs: comparative study of gentamicin, sisomicin and tobramycin in vitro and in human volunteers. Eur J Cancer (1973) 1.64
An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal amphotericin B for treatment of invasive aspergillosis. Clin Infect Dis (1998) 1.63
Antimicrobial activity of the carbenicillin-gentamicin combination against gram-negative bacilli. Am J Med Sci (1970) 1.62
Synergistic combinations of antibiotics in gram-negative bacillary infections. Rev Infect Dis (1982) 1.62
Comparative study of anti-pseudomonas activity of azlocillin, mezlocillin, and ticarcillin. Antimicrob Agents Chemother (1979) 1.62
Inhibition of chemiluminescent response of human polymorphonuclear leukocytes by hyperosmolality comparable to renal medulla and preservation by ofloxacin. Eur Urol (1991) 1.60
Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity. Am J Kidney Dis (1986) 1.59
Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for gram-negative bacilli. J Clin Microbiol (1995) 1.55
Endotracheal gentamicin in bronchial infections in patients with tracheostomy. Chest (1972) 1.55
Infections caused by Providence bacilli. Scand J Infect Dis (1974) 1.49
Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients. J Antimicrob Chemother (1991) 1.49
Tissue concentrations and bioactivity of amphotericin B in cancer patients treated with amphotericin B-deoxycholate. Antimicrob Agents Chemother (1989) 1.48
Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors. Eur J Cancer Clin Oncol (1989) 1.48
Antimicrobial activity of tobramycin and gentamicin used in combination with cephalothin and carbenicillin. Am J Med Sci (1973) 1.48
Empiric therapy for cancer patients: comparative study of ticarcillin-tobramycin, ticarcillin-cephalothin, and cephalothin-tobramycin. Antimicrob Agents Chemother (1975) 1.43
Bactericidal activity and killing rate of serum from volunteers receiving pefloxacin alone or in combination with amikacin. Antimicrob Agents Chemother (1986) 1.43
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia. Antimicrob Agents Chemother (1984) 1.41
Bacteriophage types and antibiotic susceptibility of Staphylococcus aureus. Appl Microbiol (1971) 1.40
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party. Eur J Cancer (1997) 1.40
Antibacterial activity and pharmacokinetics of bacampicillin and ampicillin. Clin Pharmacol Ther (1976) 1.39
Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. Eur J Cancer Clin Oncol (1988) 1.38
Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin. JAMA (1974) 1.38
Clinical study of combination therapy with oxacillin and rifampin for staphylococcal infections. Rev Infect Dis (1983) 1.33
Nosocomial bacteremia caused by Bacillus species. Eur J Clin Microbiol Infect Dis (1988) 1.31
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrob Agents Chemother (1995) 1.31
Serum bactericidal activity of ceftazidime and cefoperazone alone or in combination with amikacin against Pseudomonas aeruginosa and Klebsiella pneumoniae. Antimicrob Agents Chemother (1983) 1.29
Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy. Eur J Cancer Clin Oncol (1984) 1.28
Concentrations of gentamicin in bronchial secretions after intramuscular and endotracheal administration. J Clin Pharmacol (1975) 1.24
Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin. Antimicrob Agents Chemother (1987) 1.23
Pneumonia caused by gram-negative bacilli in hospitalized patients presenting malignant disease. Eur J Cancer (1971) 1.22
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. The EORTC International Antimicrobial Therapy Cooperative Group. N Engl J Med (1987) 1.21
Effect of mixing on rifampin bactericidal activity against staphylococci. Antimicrob Agents Chemother (1981) 1.21
Invasive infections due to Candida krusei: report of ten cases of fungemia that include three cases of endophthalmitis. Clin Infect Dis (1992) 1.21
Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer (1973) 1.20
Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum. J Infect Dis (1976) 1.20
Ascending myelitis in association with herpes-simplex virus. N Engl J Med (1972) 1.20
Antimicrobial effectiveness ofkanamycin, aminosidin, BB-K8, sisomicin, gentamicin and tobramycin combined with carbenicillin or cephalothin against gram-negative rods. J Med Microbiol (1974) 1.19
Prophylactic antibiotics in oral, pharyngeal and laryngeal surgery for cancer: (a double-blind study). Laryngoscope (1973) 1.19
Lactic acidosis: a metabolic complication of extensive metastatic cancer. Eur J Cancer Clin Oncol (1983) 1.18
Bactericidal activity and killing rate of serum in volunteers receiving ciprofloxacin alone or in combination with vancomycin. Antimicrob Agents Chemother (1986) 1.17
Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients. Antimicrob Agents Chemother (1986) 1.17
Effectiveness of betamethasone in management of severe infections. A double-blind study. N Engl J Med (1971) 1.16
Factors that influence cancer patients' anxiety following a medical consultation: impact of a communication skills training programme for physicians. Ann Oncol (2006) 1.16
Impact of previous aspergillosis on the outcome of bone marrow transplantation. Clin Infect Dis (1998) 1.15
High-performance liquid chromatographic determination of amphotericin B in human serum. J Chromatogr (1987) 1.15
Comparison of pharmacokinetics and bactericidal activity of teicoplanin and vancomycin. J Antimicrob Chemother (1986) 1.15
Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections. J Antimicrob Chemother (1983) 1.12
Comparative clinical study of tobramycin and gentamicin. Antimicrob Agents Chemother (1974) 1.12
Management of candidemia. N Engl J Med (1994) 1.11
Anaerobic wound infections in cancer patients: comparative trial of clindamycin, tinidazole, and doxycycline. Antimicrob Agents Chemother (1977) 1.10
Clinical and bacteriological evaluation of netilmicin in gram-negative infections. Antimicrob Agents Chemother (1977) 1.10
Factors associated with bacteraemia in febrile, granulocytopenic cancer patients. The International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer (1994) 1.10
A general chemotherapy myelotoxicity score to predict febrile neutropenia in hematological malignancies. Ann Oncol (2009) 1.08
Comparative study of tobramycin and gentamicin with special reference to anti-pseudomonas activity. Clin Pharmacol Ther (1973) 1.07
Treatment of gram-negative bacillary septicemia with cefoperazone. Eur J Clin Microbiol (1983) 1.07
Pharmacodynamic parameters and toxicity of netilmicin (6 milligrams/kilogram/day) given once daily or in three divided doses to cancer patients with urinary tract infection. Antimicrob Agents Chemother (1991) 1.07
Gram-positive infections in granulocytopenic patients: an important issue? J Antimicrob Chemother (1988) 1.07
Peripheral neuropathy associated with fluoroquinolones. Lancet (1992) 1.06
Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemia. Am J Med (1987) 1.04